Interview with Prof. Milanov and Prof. Bogdanova, published in Kapital Health, December 2022 Prof. Milanov Prof. Dr. Ivan Milanov, Ph.D., is the Executive Director of...
Sqilline and a leading pharmaceutical company have partnered to apply an AI algorithm and track high-risk patients for the rare disease of Transthyretin amyloid polyneuropathy (TTR)....
Sofia, November 14, 2022 – Dr. Gergana Shalamanova from the Oncology Center in Plovdiv showed the interesting comparison of Real-world Evidence (RWE) vs. Randomized Clinical...